Liver cancer: etiological factors
DOI:
https://doi.org/10.53591/rug.v73i3.1102Abstract
It is one of the most frequent in the world, given that there are countries with a huge incidence: in China and Africa it ranges from 25 to 150 cases per 100,000 inhabitants, while in Latin America it is 7 per 100,000. It is known that the majority Of cases of hepatoma are associated with cirrhosis or chronic hepatitis and, in general, with previous liver disease and also with nodular transformation of the liver. The common precursor in all these cases appears to be hepatocellular dysplasia. In the US, 5% of post-alcoholic cirrhosis develop hepatomas, and 50% of patients with hepatoma are cirrhotic.
References
Thomas London W. Primary hepatocellular carcinoma, etio- logy, pathogenesis and preven- tion. Hum. Pathol. 12: 1085- 1097, 1981.
Macdonald J.S., Gunerson LL, Adson M.A.- Tumores del Sistema Hepatobiliar en Cáncer: Principios y Práctica de Oncología, de De Vita, Hellman y Rosemberg. Salvat Edit, pág. 553. 1984.
Stromeyer F.W. Ishak K.G. Nodular transformation (Nodu- lar "regenerative" hyperplasia) of the liver. Hum. Pathol. 12: 60-71, 1981.
Anthony P.P., Vogel C.L., Barker L.F.- Liver cell dysplasia: a premalignant condition. J. Clin, Pathol. 26.217-1973.
Kondo Y., Niwa Y., Akikusa B. et al. A histhopatogić study of early hepatocelular carcino- ma. Cancer 52: 687-692, 1983.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0. International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.